FDA clears United Therapeutics and eGenesis for gene-edited pig kidney transplant studies, including the first clinical trial ...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

Phar­ma­ceu­ti­cal in­dus­try groups cau­tion that Pres­i­dent Don­ald Trump’s tar­iffs on Chi­na, Mex­i­co and Cana­da will ...

Fresh off a reorganization, Biogen’s research leader Jane Grogan says the biotech has to 'look outside the walls of the ...

Noom lays off coaching and customer service staff after slower-than-expected growth in prescription weight loss drug program.

For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a ...

Sen­ate Fi­nance Com­mit­tee De­moc­rats are call­ing Robert F. Kennedy Jr.’s new di­vest­ment plans to his son “plain­ly ...

Cystic fibrosis drug developer Sionna Therapeutics hopes to join the IPO wave started by Metsera and Maze Therapeutics last ...

Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...

Algiax Pharmaceuticals’ non-opioid candidate has achieved “clinically meaningful” pain reduction in a mid-stage trial of ...

Radiopharmaceuticals biotech AdvanCell has pulled together a $112 million Series C about two years after its much smaller ...